Scientific Background and Reference Sources
Adan A, Alizada G, Kiraz Y, Baran Y, Nalbant A. Flow cytometry: basic principles and applications. Crit Rev Biotechnol. Mar 2017;37(2):163-176. doi:10.3109/07388551.2015.1128876
Verbsky J, Routes J. Flow cytometry for the diagnosis of primary immunodeficiencies. Updated October 26, 2023. https://www.uptodate.com/contents/flow-cytometry-for-the-diagnosis-of-primary-immunodeficiencies
UIHC. Cancer diagnostic tests and blood tests word list. Updated July 2016. https://uihc.org/health-topics/cancer-diagnostic-tests-and-blood-tests-word-list
Pinto AE, André S, Soares J. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients. Journal of Clinical Pathology. 1999;52(8):604. doi:10.1136/jcp.52.8.604
ACS. Breast Cancer Ploidy and Cell Proliferation. Updated November 8, 2021. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/ploidy-and-cell-proliferation.html
Brown M, Wittwer C. Flow cytometry: principles and clinical applications in hematology. Clin Chem. Aug 2000;46(8 Pt 2):1221-9.
Robinson JP, Roederer M. HISTORY OF SCIENCE. Flow cytometry strikes gold. Science. Nov 13 2015;350(6262):739-40. doi:10.1126/science.aad6770
McKinnon KM. Flow Cytometry: An Overview. Curr Protoc Immunol. Feb 21 2018;120:5.1.1-5.1.11. doi:10.1002/cpim.40
Finak G, Langweiler M, Jaimes M, et al. Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium. Sci Rep. Feb 10 2016;6:20686. doi:10.1038/srep20686
Maguire O, Tario JD, Jr., Shanahan TC, Wallace PK, Minderman H. Flow cytometry and solid organ transplantation: a perfect match. Immunol Invest. 2014;43(8):756-74. doi:10.3109/08820139.2014.910022
Johnson DB, Dahlman KH, Knol J, et al. Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel. Oncologist. 2014;19(6):616-22. doi:10.1634/theoncologist.2014-0011
Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C. Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>. Annals of Oncology. 2013;24:vi39-vi50. doi:10.1093/annonc/mdt345
Horowitz NS, Eskander RN, Adelman MR, Burke W. Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: A Society of Gynecologic Oncology evidenced-based review and recommendation. Gynecologic Oncology. 2021;163(3):605-613. doi:10.1016/j.ygyno.2021.10.003
Christensen K, Hulick, Peter. Basic genetics concepts: Chromosomes and cell division. 2024;
Van der Aa N, Cheng J, Mateiu L, et al. Genome-wide copy number profiling of single cells in S-phase reveals DNA-replication domains. Nucleic acids research. Apr 2013;41(6):e66. doi:10.1093/nar/gks1352
Ermiah E, Buhmeida A, Abdalla F, et al. Prognostic value of proliferation markers: immunohistochemical ki-67 expression and cytometric s-phase fraction of women with breast cancer in libya. Journal of Cancer. 2012;3:421-31. doi:10.7150/jca.4944
Ross JS. DNA ploidy and cell cycle analysis in cancer diagnosis and prognosis. Oncology (Williston Park, NY). Jun 1996;10(6):867-82, 887; discussion 887-90.
Mangili G, Montoli S, De Marzi P, Sassi I, Aletti G, Taccagni G. The role of DNA ploidy in postoperative management of stage I endometrial cancer. Annals of oncology : official journal of the European Society for Medical Oncology. Jul 2008;19(7):1278-83. doi:10.1093/annonc/mdn041
Pinto AE, Pires A, Silva G, Bicho C, Andre S, Soares J. Ploidy and S-phase fraction as predictive markers of response to radiotherapy in cervical cancer. Pathology, research and practice. Oct 15 2011;207(10):623-7. doi:10.1016/j.prp.2011.07.007
Kenney B, Zieske A, Rinder H, Smith B. DNA ploidy analysis as an adjunct for the detection of relapse in B-lineage acute lymphoblastic leukemia. Leukemia & lymphoma. Jan 2008;49(1):42-8. doi:10.1080/10428190701760052
Bagwell CB, Clark GM, Spyratos F, et al. Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens. Cytometry. Jun 15 2001;46(3):121-35.
Gawrychowski J, Lackowska B, Gabriel A. Prognosis of the surgical treatment of patients with non-small cell lung cancer (NSCLC)--relation to DNA ploidy. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. Jun 2003;23(6):870-7; discussion 877.
Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Nov 20 2006;24(33):5313-27. doi:10.1200/jco.2006.08.2644
Abraham RS, Aubert G. Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies. Clin Vaccine Immunol. Apr 2016;23(4):254-71. doi:10.1128/cvi.00001-16
Halder M, Nath S, Jha S. Flow Cytometry and Its Utility. Chromosome Structure and Aberrations. 2017:109-126.
Cosma A, Nolan G, Gaudilliere B. Mass cytometry: The time to settle down. Cytometry A. Jan 2017;91(1):12-13. doi:10.1002/cyto.a.23032
Fromm JR, Thomas A, Wood BL. Flow cytometry can diagnose classical hodgkin lymphoma in lymph nodes with high sensitivity and specificity. Am J Clin Pathol. Mar 2009;131(3):322-32. doi:10.1309/ajcpw3un9dyldspb
Paiva B, Merino J, San Miguel JF. Utility of flow cytometry studies in the management of patients with multiple myeloma. Curr Opin Oncol. Nov 2016;28(6):511-517. doi:10.1097/cco.0000000000000331
Novikov ND, Griffin GK, Dudley G, et al. Utility of a Simple and Robust Flow Cytometry Assay for Rapid Clonality Testing in Mature Peripheral T-Cell Lymphomas. Am J Clin Pathol. Apr 2 2019;151(5):494-503. doi:10.1093/ajcp/aqy173
Wang Z, Guo M, Zhang Y, et al. The applicability of multiparameter flow cytometry for the detection of minimal residual disease using different-from-normal panels to predict relapse in patients with acute myeloid leukemia after allogeneic transplantation. Int J Lab Hematol. Oct 2019;41(5):607-614. doi:10.1111/ijlh.13070
Jin J, Mao X, Zhang D. A differential diagnosis method for systemic CAEBV and the prospect of EBV-related immune cell markers via flow cytometry. Ann Med. Dec 2024;56(1):2329136. doi:10.1080/07853890.2024.2329136
Carloni S, Gallerani G, Tesei A, et al. DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy. OncoTargets and therapy. 2017;10:4657-4664. doi:10.2147/ott.s141117
Svanvik T, Stromberg U, Holmberg E, Marcickiewicz J, Sundfeldt K. DNA ploidy status, S-phase fraction, and p53 are not independent prognostic factors for survival in endometrioid endometrial carcinoma FIGO stage I-III. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. Jan 13 2019;doi:10.1136/ijgc-2018-000082
Thomas G, Tr S, George SP, et al. Prognostic Implications of DNA Repair, Ploidy and Telomerase in the Malignant Transformation Risk Assessment of Leukoplakia. Asian Pac J Cancer Prev. Feb 1 2020;21(2):309-316. doi:10.31557/apjcp.2020.21.2.309
Taniguchi K, Suzuki A, Serizawa A, et al. Rapid Flow Cytometry of Gastrointestinal Stromal Tumours Closely Matches the Modified Fletcher Classification. Anticancer Res. Jan 2021;41(1):131-136. doi:10.21873/anticanres.14758
Panwar S, Handa U, Kaur M, Mohan H, Attri AK. Evaluation of DNA ploidy and S-phase fraction in fine needle aspirates from breast carcinoma. Diagn Cytopathol. Jun 2021;49(6):761-767. doi:10.1002/dc.24738
Rawstron AC, Kreuzer KA, Soosapilla A, et al. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project. Cytometry B Clin Cytom. Jan 2018;94(1):121-128. doi:10.1002/cyto.b.21595
Porwit A, van de Loosdrecht AA, Bettelheim P, et al. Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS. Leukemia. Sep 2014;28(9):1793-8. doi:10.1038/leu.2014.191
Davis BH, Holden JT, Bene MC, et al. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytometry B Clin Cytom. 2007;72 Suppl 1:S5-13. doi:10.1002/cyto.b.20365
Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Nov 20 2007;25(33):5287-312. doi:10.1200/jco.2007.14.2364
D. Arber MB, Melissa Cessna, Joan Etzell, Kathryn Foucar, Robert Hasserjian, J. Douglas Rizzo, Karl Theil, Sa Wang, Anthony Smith, R. Bryan Rumble, Nicole Thomas, James Vardiman. Initial Diagnostic Workup of Acute Leukemia; Guideline From the College of American Pathologists and the American Society of Hematology. Arch Pathol Lab Med. 2017;141:1342-1393. doi:10.5858/arpa.2016-0504-CP
Frelinger AL, 3rd, Rivera J, Connor DE, et al. Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet Physiology. J Thromb Haemost. Dec 2021;19(12):3193-3202. doi:10.1111/jth.15526
NCCN. NCCN Clinical Practice Guidelines in Oncology. https://www.nccn.org/guidelines/category_1
Cho KR, Cooper K, Croce S, et al. International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group. Int J Gynecol Pathol. Jan 2019;38 Suppl 1(Iss 1 Suppl 1):S114-s122. doi:10.1097/pgp.0000000000000496
Specialty Matched Consultant Advisory Panel 4/2020
Medical Director review 4/2020
Specialty Matched Consultant Advisory Panel 3/2021
Medical Director review 3/2021
Medical Director review 4/2021
Medical Director review 8/2022
Medical Director review 4/2023
Medical Director review 10/2024
Medical Director review 4/2025